Tablet coating material exported to Latin America

What this region runs

Brazil and Mexico both carry large domestic generic industries with demanding national dossier requirements. ANVISA in particular expects excipient documentation in depth, and the registration timeline reflects that.

Why our range fits it

This is the region where documentation, rather than formulation, is most often the deciding factor. It is worth establishing early exactly what your regulatory affairs team needs from an excipient supplier, because the answer here is more detailed than in most markets we serve.

What to send us

Start with your documentation list rather than the technical requirement. We would rather tell you at the outset what we can and cannot supply for an ANVISA or COFEPRIS submission than find out at dossier stage.